Lineage Cell Therapeutics Inc (LCTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | LCTX | BMY | AMGN | GILD | REGN |
| Company | Lineage Cell Therapeutics Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Regeneron Pharmaceuticals |
| Price Information | |||||
| Exchange | NYSE Arca | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 1.2200 | 48.21 | 264.63 | 66.25 | 913.97 |
| High | 1.2300 | 49.05 | 269.38 | 66.83 | 920.73 |
| Low | 1.1200 | 48.12 | 260.68 | 66.19 | 891.46 |
| Last | 1.1500 | 48.93 | 268.93 | 66.78 | 896.82 |
| Change | -0.0500 | +0.63 | +6.18 | +0.62 | +2.83 |
| % Change | -4.17% | +1.30% | +2.35% | +0.94% | +0.32% |
| Volume | 1,098,809 | 10,298,231 | 3,373,487 | 10,654,855 | 501,397 |
| 20-Day Average Volume | 1,221,210 | 11,301,910 | 2,246,094 | 6,455,813 | 437,380 |
| Previous Close | 1.2000 | 48.30 | 262.75 | 66.16 | 893.99 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 1.3385 | 50.85 | 272.56 | 69.90 | 935.18 |
| 20-Day Raw Stochastic | 6.12% | 19.17% | 29.59% | 11.04% | 7.35% |
| 20-Day Relative Strength | 45.54% | 41.16% | 43.95% | 31.41% | 34.73% |
| Weighted Alpha | -15.37 | -28.90 | +7.67 | -24.29 | +12.43 |
| Today's Opinion | 32% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Previous Opinion | 32% Buy | 72% Sell | 56% Sell | 100% Sell | 24% Buy |
| Last Month's Opinion | 40% Buy | 24% Sell | 8% Sell | 72% Sell | 80% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -11.54% since 04/12/24 | +1.35% since 04/12/24 | +0.62% since 04/12/24 | -1.90% since 04/12/24 | -0.87% since 04/12/24 |
| Low | 1.1200 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.3250 on 04/15/24 | 49.10 on 04/15/24 | 270.93 on 04/15/24 | 68.46 on 04/15/24 | 921.12 on 04/15/24 |
| 1-Month | |||||
| %Chg | -4.96% since 03/19/24 | -5.54% since 03/19/24 | -1.03% since 03/19/24 | -9.03% since 03/19/24 | -6.94% since 03/19/24 |
| Low | 1.1200 on 04/19/24 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.6100 on 03/28/24 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 74.28 on 03/21/24 | 979.26 on 03/21/24 |
| 3-Month | |||||
| %Chg | +9.52% since 01/19/24 | -2.35% since 01/19/24 | -12.63% since 01/19/24 | -23.50% since 01/19/24 | -3.92% since 01/19/24 |
| Low | 0.8414 on 02/01/24 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 890.43 on 04/16/24 |
| High | 1.6100 on 03/28/24 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 998.33 on 02/28/24 |
| 6-Month | |||||
| %Chg | -2.54% since 10/19/23 | -13.37% since 10/19/23 | -4.16% since 10/19/23 | -14.86% since 10/19/23 | +10.90% since 10/19/23 |
| Low | 0.8414 on 02/01/24 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 769.19 on 10/27/23 |
| High | 1.6100 on 03/28/24 | 57.09 on 10/20/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 998.33 on 02/28/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 226,241 | 97,892,464 | 140,812,720 | 82,374,304 | 98,126,128 |
| Shares Outstanding, K | 188,534 | 2,026,759 | 535,919 | 1,245,077 | 109,762 |
| Annual Sales | 8,950,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 13,117,200,000 |
| Annual Net Income | -21,490,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | 3,953,600,000 |
| Last Quarter Sales | 2,090,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 3,434,300,000 |
| Last Quarter Net Income | -4,780,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 1,159,600,000 |
| 60-Month Beta | 1.31 | 0.39 | 0.58 | 0.19 | 0.11 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 03/07/24 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 11.86 on 02/02/24 |
| Latest Earnings Date | 05/09/24 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | 0.080 on 12/15/03 | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.38 | 14.16 | 9.96 | 23.98 |